GDPR for Connected Medical Devices. EU-ready before launch.
If your device, app, or back-end touches any personal data of someone in the EU, patient, clinician, or research subject, you are a controller or processor under GDPR. We get MedTech and digital health companies GDPR-ready and keep them that way: aligned with MDR/IVDR, FDA, SOC 2, HITRUST, and HIPAA.
The short answer
How does GDPR apply to connected medical devices?
If a connected device or its app processes personal data of people in the EU, GDPR applies alongside the EU MDR or IVDR. Health data is a special category, so you need a lawful basis, a record of processing, data protection impact assessments, Article 32 security controls, breach response and proper contracts (DPAs and SCCs) for any transfers outside the EU.
EU-ready at launch. Not after a complaint.
- Article 30 RoPA
- Article 32 measures
- Article 35 DPIA
- SCCs + DPA pack
- MDR/IVDR aligned
- Free 30-min GDPR strategy call
- Article 30/32/35 documentation included
- EU Representative recommendations
- Aligned with MDR/IVDR Notified Body files
Fixed-fee engagement
GDPR readiness for connected devices: deliverables, inputs, and exclusions
Included work is defined in the signed proposal. These scope options are not automatic inclusions in every engagement.
Fixed-fee deliverables
- Agreed records of processing, security-control mapping, DPIA support, and data-rights/breach workflow drafts.
- Agreed DPA/SCC and transfer-assessment support materials for review by the manufacturer's privacy/legal owners.
Required inputs
- Controller/processor roles, personal-data flows, purposes, categories, locations, transfers, retention practices, and supplier contracts.
- Existing privacy notices, processing records, security evidence, and legal/privacy reviewers.
Exclusions and separate work
- Legal advice, DPO/EU representative appointment, regulatory representation, and legal approval of agreements are separate. The organization owns lawful-basis and reporting decisions.
- General software verification and validation, clinical performance testing, and full QMS implementation or certification are outside Blue Goat's product cybersecurity scope.
- The manufacturer retains engineering changes, clinical-risk evaluation, risk acceptance, release approval, and regulatory submission decisions. No regulatory outcome is promised.
Pricing and scope changes
A written fixed-fee quote after scoping. The proposal names deliverables, versions, assumptions, required inputs, exclusions, and agreed dates. Additional work requires a separately agreed scope change. Missing inputs, access restrictions, manufacturer fixes, and review feedback can affect delivery.
Why US MedTech teams trip on GDPR
GDPR is not 'HIPAA with European wording.' EU regulators evaluate evidence Americans aren't used to producing.
No Article 30 records
EU supervisory authorities ask for Records of Processing on day one of any inquiry. A privacy policy on the website is not enough. Most US MedTech teams have nothing on file.
No DPIA for the device
Connected medical devices and large-scale processing of health data are explicitly listed as high-risk in nearly every EU member-state DPIA blacklist. A DPIA isn't optional. It's the document the supervisory authority will read first.
Broken transfer mechanism
Post-Schrems II, sending EU patient data to US cloud regions requires SCCs, a Transfer Impact Assessment, and supplementary measures. 'It's encrypted' is not a defense.
Documentation and controls we deliver
Everything an EU supervisory authority, Notified Body, or hospital DPO would ask to see: in a maintainable form, not a one-time PDF.
Records & assessments
- Article 30 Records of Processing (controller + processor)
- Article 35 DPIA for the device and connected services
- Transfer Impact Assessments (TIAs) for international transfers
- Annual review and update workflow
Article 32 technical measures
- Encryption in transit and at rest with key management
- Pseudonymisation where feasible
- Backup, restore, and resilience testing
- Logging, alerting, and incident response runbook
Data-subject rights
- Access, rectification, erasure, portability, objection workflows
- Role assignments and SLAs (typically 1 month)
- Tooling integration with your support and engineering systems
- Audit log of every request and outcome
Contracts & governance
- DPA template to send to your customers
- Signed DPAs with every sub-processor
- SCCs + supplementary measures for transfers
- EU Representative recommendation if you don't have an EU establishment
How the GDPR program runs
Mapped in weeks 1-3. Documentation in months 1-3. Operating program by month 6.
- 01
1. Scoping & data mapping
Weeks 1-3: map every personal-data flow across device, app, cloud, support, sales, and analytics. Identify controller vs processor roles for each activity.
- 02
2. Records, DPIA, and contracts
Months 1-3: produce Article 30 RoPA, the DPIA for the device, the DPA pack, SCCs, TIAs, and EU Representative recommendation.
- 03
3. Article 32 measures + rights workflows
Months 2-4: align technical measures with your existing SOC 2 / HITRUST controls. Stand up data-subject rights workflows and the 72-hour breach response runbook.
- 04
4. Embed and operate
Months 4-6: train the team, integrate with your QMS so MDR/IVDR Notified Body files reference the GDPR artifacts, and establish the annual review cycle.
Reviewer-ready deliverables in one engagement
Every engagement ships with documented artifacts, traceable, complete, and aligned with current guidance.
- Records of Processing Activities (Art. 30) for controller and processor activities
- Article 32 technical measures mapped to your existing controls
- DPIA for the device and its connected services
- 72-hour breach response runbook and notification templates
- Data-subject rights workflows with SLAs
- DPA / SCC pack and Transfer Impact Assessments
GDPR for MedTech FAQs
Cybersecurity alerts and guides
Goat's Weekly alerts
Medical device advisories and safety communications, with links to original sources. An alert is a reason to assess applicability, not proof that your device is affected.
Threat modeling, eSTAR 7.1, and SBOM evidence
Connect threats to controls and test evidence. Compare the CISA 2026 SBOM fields with the NTIA 2021 baseline the FDA still cites, plus its support fields. Guidance recommendations remain separate from statutory duties.
GDPR compliance for medical devices - DPIAs, TIAs, Article 32.
If your device, app, or back-end touches any personal data of someone in the EU, patient, clinician, or research subject, you are a controller or processor under GDPR. We get MedTech and digital health companies GDPR-ready and keep them that way: aligned with MDR/IVDR, FDA, SOC 2, HITRUST, and HIPAA.